Ardent Health, Inc. (ARDT)
NYSE: ARDT · Real-Time Price · USD
17.65
+0.35 (2.02%)
Nov 9, 2026, 9:50 AM EST - Market open

Ardent Health Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
146.22135.81210.3453.9188.91154.26
Depreciation & Amortization
166.42155.7146.29140.84138.17137.2
Other Amortization
3.244.385.474.995.76.43
Loss (Gain) From Sale of Assets
-----161.16-0.11
Loss (Gain) on Equity Investments
-11.89-1.045.84-1.65-7.52-2.91
Stock-Based Compensation
33.339.2917.980.90.610.55
Other Operating Activities
121.63139.71110.8779.02122.58112.61
Change in Accounts Receivable
33.4359.1640-181.1-17.18-96.47
Change in Inventory
5.12-3.15-9.411.674.67-5.73
Change in Accounts Payable
-2.1562.06-103.86136.8214.42109.35
Change in Other Net Operating Assets
-13.47-121.41-108.49-13.7-327.56-268.28
Operating Cash Flow
481.88470.51315.03221.7-38.36146.91
Operating Cash Flow Growth
31.43%49.36%42.10%---7.94%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-199.57-211.9-187.51-137.41-151.11-139
Cash Acquisitions
-2.5-2.5-35.54---2.93
Divestitures
--4.3-206.370.65
Sale (Purchase) of Real Estate
-----3.56
Other Investing Activities
8.630.18-1.71-0.58-8.691.47
Investing Cash Flow
-193.45-214.23-220.46-137.9846.58-136.26

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
---125204-
Long-Term Debt Issued
-15.6114.431.375.221,199
Total Debt Issued
23.4915.6114.4156.37209.221,199
Short-Term Debt Repaid
----125-202.05-
Long-Term Debt Repaid
--23.03-118.81-36.52-21.08-1,284
Total Debt Repaid
-32.98-23.03-118.81-161.52-223.13-1,284
Net Debt Issued (Repaid)
-9.49-7.42-104.42-5.15-13.91-84.61
Issuance of Common Stock
--208.66---
Repurchase of Common Stock
-24.01-----
Common Dividends Paid
-----174.81-62.13
Dividends Paid
-----174.81-62.13
Other Financing Activities
-98.13-96.04-79.6-97.11-81.61-137.17
Financing Cash Flow
-131.63-103.4724.64-102.26-270.33-283.91

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
156.8152.82119.21-18.55-262.11-273.26

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
282.3258.61127.5284.29-189.477.91
Free Cash Flow Growth
79.29%102.80%51.29%---
Free Cash Flow Margin
4.37%4.09%2.14%1.56%-3.69%0.16%
Free Cash Flow Per Share
1.991.830.960.67-1.50-
Levered Free Cash Flow
185.77154.2250.0755.07--
Unlevered Free Cash Flow
215.32184.3485.5996.52--

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
65.7465.7474.9881.6190.85100.22
Cash Income Tax Paid
36.5136.5141.619.4355.8232.16
Change in Working Capital
22.94-3.34-181.75-56.31-325.65-261.13
SEC Filings: 10-K · 10-Q